Enzyme-Activated Sugar-Coated Bifunctional Degraders
- 12 September 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
Abstract
Targeted protein degradation with compounds like proteolysis targeting chimeras (PROTACs) directs disease-associated proteins to the E3 ligase ubiquitin-proteasome system for removal. However, commonly employed E3 ligases such as cereblon (CRBN) are broadly expressed. To metabolically gate PROTAC activity, we developed an enzymatic activation strategy by integrating an O-GlcNAc modification to the cyclimids, ligands derived from the natural motifs recognized by CRBN. These sugar-coated PROTACs (SCPs) were designed using structural analyses of representative cyclimid degraders complexed with CRBN and target protein BRD4. We found that glycosylation of the cyclimid reduced CRBN binding and complex formation with BRD4 until enzymatic removal of the O-GlcNAc moiety by O-GlcNAcase (OGA). The requirement for enzymatic activation is demonstrated by in vitro biochemical binding, cellular degradation, and cell viability assays in engineered and native cell lines. O-GlcNAc is thus an effective mechanism to gate targeted protein degradation modalities that motivates the development of similar strategies to enhance selectivity with other protein modifications.Keywords
Funding Information
- National Science Foundation Graduate Research Fellowship Program
- Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- National Institute on Aging (1RF1AG081475)
- National Institute of General Medical Sciences (R01GM141406)
This publication has 40 references indexed in Scilit:
- Accelerating PROTACs Discovery Through a Direct‐to‐Biology Platform Enabled by Modular Photoclick ChemistryAdvanced Science, 2024
- Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACsJournal of Medicinal Chemistry, 2024
- The cyclimids: Degron-inspired cereblon binders for targeted protein degradationCell Chemical Biology, 2024
- Recent Advances in Pro-PROTAC Development to Address On-Target Off-Tumor ToxicityJournal of Medicinal Chemistry, 2023
- Identification and structural basis of C-terminal cyclic imides as natural degrons for cereblonBiochemical and Biophysical Research Communications, 2022
- Rational Design for Nitroreductase (NTR)-Responsive Proteolysis Targeting Chimeras (PROTACs) Selectively Targeting Tumor TissuesJournal of Medicinal Chemistry, 2022
- Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological DiscoveryCell, 2020
- Molecular mechanisms regulating O-linked N-acetylglucosamine (O-GlcNAc)–processing enzymesCurrent Opinion in Chemical Biology, 2019
- Intracellular Protein O-GlcNAc Modification Integrates Nutrient Status with Transcriptional and Metabolic Regulation2015
- O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulationCurrent Opinion in Chemical Biology, 2012